\BOOKMARK [1][-]{section.1}{Introduction}{}% 1
\BOOKMARK [1][-]{section.2}{Method}{}% 2
\BOOKMARK [2][-]{subsection.2.1}{Evaluation}{section.2}% 3
\BOOKMARK [3][-]{subsubsection.2.1.1}{COVID-19\040Category\040\(CC\)}{subsection.2.1}% 4
\BOOKMARK [3][-]{subsubsection.2.1.2}{Vaccine\040Sentiment\040\(VS\)}{subsection.2.1}% 5
\BOOKMARK [3][-]{subsubsection.2.1.3}{Maternal\040Vaccine\040Stance\040\(MVS\)}{subsection.2.1}% 6
\BOOKMARK [3][-]{subsubsection.2.1.4}{Twitter\040Sentiment\040SemEval\040\(SE\)}{subsection.2.1}% 7
\BOOKMARK [3][-]{subsubsection.2.1.5}{Stanford\040Sentiment\040Treebank\0402\040\(SST-2\)}{subsection.2.1}% 8
\BOOKMARK [1][-]{section.3}{Results}{}% 9
\BOOKMARK [2][-]{subsection.3.1}{Domain-sepcific\040pretraining}{section.3}% 10
\BOOKMARK [2][-]{subsection.3.2}{Evaluation\040on\040classification\040datasets}{section.3}% 11
\BOOKMARK [2][-]{subsection.3.3}{Evaluation\040on\040intermediary\040pretraining\040checkpoints}{section.3}% 12
\BOOKMARK [1][-]{section.4}{Discussion}{}% 13
\BOOKMARK [1][-]{section.5}{Data\040Availability}{}% 14
\BOOKMARK [1][-]{section.6}{Funding}{}% 15
\BOOKMARK [1][-]{section.7}{Conflicts\040of\040Interest}{}% 16
